E. Kostenis et al., EVIDENCE FOR A MULTIPLE BINDING MODE OF BISPYRIDINIUM-TYPE ALLOSTERICMODULATORS OF MUSCARINIC RECEPTORS, European journal of pharmacology, 314(3), 1996, pp. 385-392
The ligand binding properties of muscarinic receptors can be modulated
by allosterically acting compounds. Here, a set of novel bispyridiniu
m-type compounds was investigated which were designed to study structu
re-activity relationships and to provide more insight into the molecul
ar events underlying the allosteric delay of the dissociation of [H-3]
N-methylscopolamine from muscarinic M(2) receptors in porcine cardiac
membranes. The parent compound, a non-substituted bispyridinium oxime,
displayed a weak allosteric potency and was unable to prevent radioli
gand dissociation at maximum concentrations. Introduction of either a
phthalimidomethyl-moiety or a dichlorobenzyl-moiety at one end of the
parent compound led to a considerable increase of the allosteric activ
ity with regard to both the potency and the maximum effect. In these u
nilaterally ring-substituted bispyridiniums, homologous contralateral
non-aromatic modifications were accompanied by divergent potency shift
s depending on whether the unilateral ring was phthalimidomethyl or di
chlorobenzyl. The findings point to a multiple binding mode of bispyri
dinium compounds at M(2) receptors in the [H-3]N-methylscopolamine-occ
upied state, i.e., different orientations of the compounds at the allo
steric binding area or even an interaction with distinct allosteric re
cognition sites.